We quantified the areas of both IGFBP2 staining and cytokeratin staining (representing total tumor area), and calculated the percent IGFBP2 positive area per tumor area in order to normalize to the amount of tumor present in each sample (Datafile 2). This evidence concerns the gene IGFBP2 and neoplasm.